A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.
One new story for each specialty, every morning: short, sourced and readable between patients.
None of today's stories are in your chosen specialties. Change specialties or browse all of MedShorts 360.
CardiologyAn analysis of more than 44 million US births presented at AHA 2026 found chronic maternal hypertension and pre-existing diabetes were associated with a higher likelihood of critical congenital heart disease in the newborn.
DiabetologyIn 963 DCCT/EDIC participants with about 43 years of type 1 diabetes, 64% screened at moderate-to-high risk for obstructive sleep apnoea and 43% reported poor sleep; higher HbA1c and complications were linked to sleep problems.
NephrologyInterim phase 3 data presented at ASN Kidney Week showed the complement factor B antisense drug sefaxersen reduced 24-hour proteinuria by 43.1% versus placebo at 37 weeks, with more haematuria resolution and some liver enzyme rises.
NeurologyUsing MRI data from 21,977 people, Yale researchers built normative brain volume centiles; in 603 ADNI participants, each one-unit lower z-score raised the risk of progression to CDR 0.5 or more by 24%.
UrologyThe American Cancer Society's updated early-detection guideline recommends biennial PSA screening for average-risk men aged 50-69, annual screening from 45 for Black men and men with a strong family history, and MRI or biomarkers before biopsy.
PsychiatryIn nearly 11,900 youths aged 9-17 and their caregivers, most diagnoses were endorsed by only one informant. Teens more often reported depression, suicidality and self-harm, while caregivers more often reported conduct, eating and anxiety disorders.
PulmonologyIndia's estimated TB death rate fell from 28 to 18 per lakh between 2015 and 2025, a 38% drop against 35% globally, with 94% treatment success in drug-susceptible TB, the Health Ministry said as the WHO report was released.
Critical CareIn a five-year trial across 60 North Carolina counties and 22,459 out-of-hospital cardiac arrests, community CPR training, dispatcher coaching and first-responder defibrillation did not raise survival with good brain function (9.0% vs 9.4%).
GastroenterologyTwo US studies at ACAAI 2026 found eosinophilic oesophagitis is rising sharply and can be misread as recurrent food anaphylaxis, with patients waiting a mean of about 5.5 years for the correct diagnosis.
DermatologyTopline phase 3 results show the oral IL-23 receptor-blocking peptide icotrokinra outperformed placebo at week 16 and was noninferior to ustekinumab at week 28 in moderate-to-severe plaque psoriasis.
OphthalmologyA meta-analysis of nine studies covering 1,187 eyes found the IPCL and ICL phakic lenses gave comparable uncorrected and corrected distance vision, with toric ICLs showing better rotational stability.
ENTA two-patient report in the Indian Journal of Otolaryngology describes young men with recurrent epistaxis after nasal surgery in whom normal routine coagulation tests had missed underlying platelet problems.
OrthopaedicsIn a UK phase 2a trial of 63 adults with severe fibromyalgia, weekly rozanolixizumab cut pain interference slightly versus placebo but did not reduce pain intensity or fatigue.
GynaecologyIn 760 pregnancies complicated by both gestational diabetes and pre-eclampsia, higher maternal homocysteine and coagulation-fibrinolysis markers were independently associated with small-for-gestational-age birth.
PaediatricsScreening of 730 children in Puducherry and Tamil Nadu found 8.4% screen-positive for neurodevelopmental disorders, with higher odds among preterm-born and school-aged children.
SurgeryAn analysis of five studies presented at ANESTHESIOLOGY 2026 linked cannabis use to more perioperative myocardial infarction and fewer venous clots, with no difference in stroke, kidney injury or death.
General MedicineIn a four-week placebo-controlled trial of 50 middle-aged adults with obesity, urolithin A 1,000 mg daily did not significantly improve flow-mediated dilation, though task-related cerebral blood flow responses increased.
Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.
Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.
MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.
The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.
Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.
Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.
Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.
Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.
When all three roles learn from the same source, the patient hears one consistent story about their treatment.
Learns the evidence, passes certification, shares an approved MedShorts link.
Reviews the update in minutes, prescribes with the latest guidance, shares patient material.
Dispenses correctly and counsels on dose, timing, side-effects and adherence.
Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.
Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.
Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.
Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.
Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.
Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.
A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.
One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.
Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.
Apply it in practice, share patient material, or continue to a full CME course.
Engagement flows into the brand dashboard and shapes the next content cycle.
Two-to-three-minute reads on a single clinical question.
Expert perspectives in three-to-five-minute clips.
Landmark and recent trials summarised with key numbers.
What changed, and what it means in clinic.
Test and reinforce, with instant explanations.
Leaflets and videos doctors and pharmacists can share.
Lung-sound and ECG trainers, calculators and checklists.
Interaction, storage and pharmacovigilance reminders.
MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.
The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.
Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.